Please kindly note that the virtual course programme timings are to be considered CEST (Central European Summer Time)
- To acquire insights in the preclinical and clinical development of vaccines and cellular immunotherapeutic approaches against cancer
- To learn about advances and ongoing research in optimal combinations of immunotherapeutic approaches involving vaccines and cell effectors, along with prognostic and predictive biomarkers
- To obtain in-depth understanding of perspectives, bottlenecks and unmet needs in the evolving field of cancer vaccines and cellular immunotherapies
Download the preliminary programme
How to apply
Application is via online form. During the application process you will be required to upload the following:
- Your CV including a list of your publications
Applications for the virtual course will close on Wednesday, 23 March 2022.
Who can apply?
While this course is primarily aimed at experienced oncologists resident in Europe, application is open to all ESMO members.
To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.
Successful applicants will benefit from complimentary registration for this virtual course.
The programme of this virtual event has been accredited with 7 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Andrew Furness, United Kingdom
Pedro Romero, Switzerland